Harvard's new kidney engineering technology licensed to San Diego-based Trestle Biotherapeutics

A newly launched startup is building upon innovations developed over several years at the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard John A. Paulson School of Engineering & Applied Sciences (SEAS), and Brigham and Women’s Hospital (Brigham) to engineer functional kidney tissue for renal repair and replacement therapy.

Related Keywords

Boston , Massachusetts , United States , Aimee Molineux , Joseph Bonventre , Jennifer Lewis , Ruji Morizane , Alice Chen , Biotherapeutics Jennifer Lewi , Ryuji Morizane , Ben Shepherd , Donald Ingber , Engineering In Medicine Division , Harvard Stem Cell Institute , Harvard Medical School , Wyss Institute Organ Engineering Initiative , Wyss Institute , Division Of Renal Medicine , Harvard Wyss Institute , Harvard Office Of Technology Development , Sciences Engineering Accelerator , Harvard Johna Paulson School Of Engineering , Wyss Institute At Harvard University , Lewis Lab , Biologically Inspired Engineering , Harvard University , Harvard John , Applied Sciences , Jennifer Lewi , Technology Development , Wyss Core Faculty , Organ Engineering Initiative , Wyss Professor , Affiliated Faculty , Renal Medicine , Founding Chief , Medicine Division , Assistant Professor , Massachusetts General Hospital , Visiting Scholar , Engineering Accelerator , Nature Methods , Wyss Founding Director Donald Ingber , Judah Folkman Professor , Vascular Biology , Boston Children , Biotherapeutics , Kidney , Bioprinting , Fell , Cell Biology , Hronic , Dialysis , Disease Modeling , Hospital , N Vitro , Kidney Disease , Kidney Failure , Medicine , Rganoids , Mh , Herapeutics , Tissue Engineering , Ascular ,